According to the report, the global Hepatitis E Diagnostic Tests Market is anticipated to reach US$ 60.43 Mn in 2024 at a CAGR of 3.8% from 2016 to 2024.
The report provides detailed analysis of the current and emerging trends in the hepatitis E diagnostic tests market. The market size has been provided for test type, and end-user segments. Based on test type, the market has been segmented into ELISA HEV IgM test kits, ELISA HEV IgM test kits, RT-PCR test kits, and others. Based on end user, the market has been segmented into hospitals, diagnostic laboratories, research centers, and point of care. The report provides forecasts for revenue (US$ Mn) of the test type and end user from 2016–2024.
ELISA HEV IgM test kits are expected to be the dominant test type segment in the forecast period, owing to its application as the primary test for the diagnosis of hepatitis E infections. The growing sero-prevalence of hepatitis E globally, leads to an increase in the acute cases of infection contributing to the increasing demand for the ELISA HEV IgM test kits in the market. In addition, the hyper-endemic prevalence of hepatitis E in various countries of Asia Pacific and Africa contribute to the increase in the demand for the diagnostic kits in the forecast period. In addition, the lack of proper sanitation facilities, and lack of access to safe drinking water in the rural areas of developing regions, also contributes to the increasing spread of the disease, contributing to the growth in the number of acute infections. This segment is expected to be followed by RT-PCR segment as this test is considered as the direct test for the diagnosis of acute infections of hepatitis E. In addition, RT-PCR test is the confirmatory test for the identification of acute HEV infections as it is based on the detection of HEV-RNA in the human serum, plasma or fecal samples. The market for ELISA HEV IgG test kits is expected to record a modest growth as these test kits are used to estimate the sero-prevalence rates of hepatitis E in the geographic regions. The presence of IgG titers in the test sample indicates that the individual has been previously infected by HEV. According to WHO, over 20.1 million cases of infection are estimated globally, of which over 3.3 million are symptomatic cases, leading to over 70,000 deaths and 3,000 stillbirths.
Inquire for Sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16859
Research centers and diagnostic laboratories are expected to record a strong growth in the hepatitis E diagnostic tests market. The growing sero-prevalence of hepatitis E, which was once considered as a silent disease, has contributed to the increase in the research on the modes of transmission of the disease, which is contributing to the growth of the research centers. In addition, studies are being conducted on the severe complications of hepatitis E, and the mode of infection of various genotypes of hepatitis E, which positively adds to the revenue share of research centers in the hepatitis E diagnostic tests market. Hepatitis E is known to cause severe infection leading to fulminant hepatitis, ultimately causing death. The rate of death among pregnant women is known to be around 15% and 20%. This high rate of death among pregnant women, has contributed to the increasing screening for hepatitis E among pregnant women, contributing to the increasing revenue share of diagnostic laboratories. The modest growth in the hospitals segment can be attributed to the growing focus on screening for hepatitis E among the blood donors.
Major players in the hepatitis E diagnostic tests market include altona Diagnostics GmbH, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Biokit S.A., Dia.Pro – Diagnostic Bioprobes s.r.l, F. Hoffmann-La Roche Ltd., Fast-track diagnostics Ltd., Fortress Diagnostics Limited, Mikrogen GmBH, MP Biomedicals, LLC., and Primerdesign Ltd., among others. The market players have well developed distribution networks, which enable them to effectively distribute their products globally.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453